243 related articles for article (PubMed ID: 38324228)
21. Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapor synthesis can target GLUT1 overexpressing tumors: In vitro tests and in vivo preliminary assessment.
Barbaro D; Di Bari L; Gandin V; Marzano C; Ciaramella A; Malventi M; Evangelisti C
PLoS One; 2022; 17(6):e0269603. PubMed ID: 35704647
[TBL] [Abstract][Full Text] [Related]
22. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.
Vakili-Ghartavol R; Momtazi-Borojeni AA; Vakili-Ghartavol Z; Aiyelabegan HT; Jaafari MR; Rezayat SM; Arbabi Bidgoli S
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):443-451. PubMed ID: 32024389
[TBL] [Abstract][Full Text] [Related]
23. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
[TBL] [Abstract][Full Text] [Related]
25. Superparamagnetic Iron Oxide Nanoparticles: Cytotoxicity, Metabolism, and Cellular Behavior in Biomedicine Applications.
Wei H; Hu Y; Wang J; Gao X; Qian X; Tang M
Int J Nanomedicine; 2021; 16():6097-6113. PubMed ID: 34511908
[TBL] [Abstract][Full Text] [Related]
26. Differential effect of polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles on BT-474 human breast cancer cell viability.
Aliakbari M; Mohammadian E; Esmaeili A; Pahlevanneshan Z
Toxicol In Vitro; 2019 Feb; 54():114-122. PubMed ID: 30266435
[TBL] [Abstract][Full Text] [Related]
27. Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers.
Talluri S; Malla RR
Curr Drug Metab; 2019; 20(12):942-945. PubMed ID: 31622217
[TBL] [Abstract][Full Text] [Related]
28. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
29. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
30. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Mahmoudi M; Sant S; Wang B; Laurent S; Sen T
Adv Drug Deliv Rev; 2011; 63(1-2):24-46. PubMed ID: 20685224
[TBL] [Abstract][Full Text] [Related]
31. Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration.
Pham BTT; Colvin EK; Pham NTH; Kim BJ; Fuller ES; Moon EA; Barbey R; Yuen S; Rickman BH; Bryce NS; Bickley S; Tanudji M; Jones SK; Howell VM; Hawkett BS
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320407
[TBL] [Abstract][Full Text] [Related]
32. Superparamagnetic iron oxide nanoparticles (SPIONs): synthesis and surface modification techniques for use with MRI and other biomedical applications.
Yoffe S; Leshuk T; Everett P; Gu F
Curr Pharm Des; 2013; 19(3):493-509. PubMed ID: 22934920
[TBL] [Abstract][Full Text] [Related]
33. Polyethylene Glycol-Chitosan Oligosaccharide-Coated Superparamagnetic Iron Oxide Nanoparticles: A Novel Drug Delivery System for Curcumin Diglutaric Acid.
Sorasitthiyanukarn FN; Muangnoi C; Thaweesest W; Bhuket PRN; Jantaratana P; Rojsitthisak P; Rojsitthisak P
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906490
[TBL] [Abstract][Full Text] [Related]
34. New Frontiers in Molecular Imaging with Superparamagnetic Iron Oxide Nanoparticles (SPIONs): Efficacy, Toxicity, and Future Applications.
Frantellizzi V; Conte M; Pontico M; Pani A; Pani R; De Vincentis G
Nucl Med Mol Imaging; 2020 Apr; 54(2):65-80. PubMed ID: 32377258
[TBL] [Abstract][Full Text] [Related]
35. Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications.
Dulińska-Litewka J; Łazarczyk A; Hałubiec P; Szafrański O; Karnas K; Karewicz A
Materials (Basel); 2019 Feb; 12(4):. PubMed ID: 30791358
[TBL] [Abstract][Full Text] [Related]
36. Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.
Shevtsov M; Multhoff G
Curr Drug Metab; 2016; 17(8):737-744. PubMed ID: 27280470
[TBL] [Abstract][Full Text] [Related]
37. Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.
Lee CM; Cheong SJ; Kim EM; Lim ST; Jeong YY; Sohn MH; Jeong HJ
J Nucl Med; 2013 Nov; 54(11):1974-80. PubMed ID: 24050935
[TBL] [Abstract][Full Text] [Related]
38. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.
Silva AH; Lima E; Mansilla MV; Zysler RD; Troiani H; Pisciotti MLM; Locatelli C; Benech JC; Oddone N; Zoldan VC; Winter E; Pasa AA; Creczynski-Pasa TB
Nanomedicine; 2016 May; 12(4):909-919. PubMed ID: 26767515
[TBL] [Abstract][Full Text] [Related]
39. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.
Wahajuddin ; Arora S
Int J Nanomedicine; 2012; 7():3445-71. PubMed ID: 22848170
[TBL] [Abstract][Full Text] [Related]
40. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications.
Lin MM; Kim DK; El Haj AJ; Dobson J
IEEE Trans Nanobioscience; 2008 Dec; 7(4):298-305. PubMed ID: 19203873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
